Pt Hetzer Medical Stock Price To Earning
MEDS Stock | 50.00 0.00 0.00% |
PT Hetzer Medical fundamentals help investors to digest information that contributes to PT Hetzer's financial success or failures. It also enables traders to predict the movement of MEDS Stock. The fundamental analysis module provides a way to measure PT Hetzer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Hetzer stock.
MEDS |
PT Hetzer Medical Company Price To Earning Analysis
PT Hetzer's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Based on the latest financial disclosure, PT Hetzer Medical has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The price to earning for all Indonesia stocks is 100.0% higher than that of the company.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
MEDS Fundamentals
Profit Margin | (0.08) % | |||
Operating Margin | 0.12 % | |||
Shares Outstanding | 1.56 B | |||
Shares Owned By Insiders | 8.00 % | |||
Price To Sales | 5.97 X | |||
Revenue | 43.99 B | |||
Gross Profit | 53.98 B | |||
EBITDA | 7.68 B | |||
Book Value Per Share | 45.78 X | |||
Number Of Employees | 25 | |||
Market Capitalization | 231.25 B |
About PT Hetzer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Hetzer Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Hetzer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Hetzer Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.